Skip to main content
Top
Published in: Cancer Cell International 1/2013

Open Access 01-12-2013 | Primary research

Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis

Authors: Yubiao Guo, Junna Hou, Yifeng Luo, Dujuan Wang

Published in: Cancer Cell International | Issue 1/2013

Login to get access

Abstract

Background

Macrophage migration inhibitory factor (MIF) is important in regulating cell proliferation and apoptosis in both normal and cancerous cells, and may be important in cancer progression and metastasis. In human non-small cell lung cancer (NSCLC), the underlying mechanisms responsible for MIF-dependent regulation of cellular proliferation, and cell death remain poorly appreciated.

Methods

The human H460 lung cancer cell-line was treated with an optimally determined dose of 50 pmol/ml MIF siRNA, following which cell proliferation, cell cycle and apoptosis were analyzed. Additionally, known pathways of apoptosis including expression of Annexin-V, enhanced production of caspases-3 and −4 and expression of the Akt signaling protein were assessed in an attempt to provide insights into the signaling pathways involved in apoptosis following disruption of MIF expression.

Results

Specific siRNA sequences markedly decreased MIF expression in H460 cells by 2 to 5-fold as compared with the negative control. Moreover, MIF miRNA dampened not only cellular proliferation, but increased the frequency of apoptotic cells as assessed by cell-surface Annexin-V expression. Entry of cells into apoptosis was partly dependent on enhanced production of caspases −3 and −4 while not affecting the expression of either caspase-8 or the Akt signaling pathway.

Conclusions

In a model of NSCLC, knockdown of MIF mRNA expression dampened H460 proliferation by mechanisms partly dependent on entry of cells into apoptosis and enhanced production of caspase-3 and −4. MIF expression may thus be important in NSCLC progression. Targeting MIF may have clinical utility in the management of human lung cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin. 2010, 60 (5): 277-300. 10.3322/caac.20073.CrossRefPubMed Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin. 2010, 60 (5): 277-300. 10.3322/caac.20073.CrossRefPubMed
2.
go back to reference Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002, 346 (2): 92-98. 10.1056/NEJMoa011954.CrossRefPubMed Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002, 346 (2): 92-98. 10.1056/NEJMoa011954.CrossRefPubMed
3.
go back to reference Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH: Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med. 2006, 355 (24): 2542-2550. 10.1056/NEJMoa061884.CrossRefPubMed Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH: Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med. 2006, 355 (24): 2542-2550. 10.1056/NEJMoa061884.CrossRefPubMed
4.
go back to reference Carney DN: Lung cancer–time to move on from chemotherapy. New Engl J Med. 2002, 346 (2): 126-128. 10.1056/NEJM200201103460211.CrossRefPubMed Carney DN: Lung cancer–time to move on from chemotherapy. New Engl J Med. 2002, 346 (2): 126-128. 10.1056/NEJM200201103460211.CrossRefPubMed
5.
go back to reference Calandra T, Bernhagen J, Mitchell RA, Bucala R: The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 1994, 179 (6): 1895-1902. 10.1084/jem.179.6.1895.CrossRefPubMed Calandra T, Bernhagen J, Mitchell RA, Bucala R: The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 1994, 179 (6): 1895-1902. 10.1084/jem.179.6.1895.CrossRefPubMed
6.
go back to reference Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R: An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA. 1996, 93 (15): 7849-7854. 10.1073/pnas.93.15.7849.PubMedCentralCrossRefPubMed Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R: An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA. 1996, 93 (15): 7849-7854. 10.1073/pnas.93.15.7849.PubMedCentralCrossRefPubMed
7.
go back to reference Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN, Bucala R, Donnelly SC: Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest. 1998, 101 (12): 2869-2874. 10.1172/JCI1524.PubMedCentralCrossRefPubMed Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN, Bucala R, Donnelly SC: Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest. 1998, 101 (12): 2869-2874. 10.1172/JCI1524.PubMedCentralCrossRefPubMed
8.
go back to reference Imamura K, Nishihira J, Suzuki M, Yasuda K, Sasaki S, Kusunoki Y, Tochimaru H, Takekoshi Y: Identification and immunohistochemical localization of macrophage migration inhibitory factor in human kidney. Biochem Mol Biol Int. 1996, 40 (6): 1233-1242.PubMed Imamura K, Nishihira J, Suzuki M, Yasuda K, Sasaki S, Kusunoki Y, Tochimaru H, Takekoshi Y: Identification and immunohistochemical localization of macrophage migration inhibitory factor in human kidney. Biochem Mol Biol Int. 1996, 40 (6): 1233-1242.PubMed
9.
go back to reference Nishihira J, Koyama Y, Mizue Y: Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine. 1998, 10 (3): 199-205. 10.1006/cyto.1997.0276.CrossRefPubMed Nishihira J, Koyama Y, Mizue Y: Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine. 1998, 10 (3): 199-205. 10.1006/cyto.1997.0276.CrossRefPubMed
10.
go back to reference McClelland M, Zhao L, Carskadon S, Arenberg D: Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer. Am J Pathol. 2009, 174 (2): 638-646. 10.2353/ajpath.2009.080463.PubMedCentralCrossRefPubMed McClelland M, Zhao L, Carskadon S, Arenberg D: Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer. Am J Pathol. 2009, 174 (2): 638-646. 10.2353/ajpath.2009.080463.PubMedCentralCrossRefPubMed
11.
go back to reference White ES, Flaherty KR, Carskadon S, Brant A, Iannettoni MD, Yee J, Orringer MB, Arenberg DA: Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res. 2003, 9 (2): 853-860.PubMed White ES, Flaherty KR, Carskadon S, Brant A, Iannettoni MD, Yee J, Orringer MB, Arenberg DA: Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res. 2003, 9 (2): 853-860.PubMed
12.
go back to reference Kayser K, Nwoye JO, Kosjerina Z, Goldmann T, Vollmer E, Kaltner H, Andre S, Gabius HJ: Atypical adenomatous hyperplasia of lung: its incidence and analysis of clinical, glycohistochemical and structural features including newly defined growth regulators and vascularization. Lung Cancer. 2003, 42 (2): 171-182. 10.1016/S0169-5002(03)00289-7.CrossRefPubMed Kayser K, Nwoye JO, Kosjerina Z, Goldmann T, Vollmer E, Kaltner H, Andre S, Gabius HJ: Atypical adenomatous hyperplasia of lung: its incidence and analysis of clinical, glycohistochemical and structural features including newly defined growth regulators and vascularization. Lung Cancer. 2003, 42 (2): 171-182. 10.1016/S0169-5002(03)00289-7.CrossRefPubMed
13.
go back to reference Rendon BE, Roger T, Teneng I, Zhao M, Al-Abed Y, Calandra T, Mitchell RA: Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem. 2007, 282 (41): 29910-29918. 10.1074/jbc.M704898200.CrossRefPubMed Rendon BE, Roger T, Teneng I, Zhao M, Al-Abed Y, Calandra T, Mitchell RA: Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem. 2007, 282 (41): 29910-29918. 10.1074/jbc.M704898200.CrossRefPubMed
14.
go back to reference Hauck CR, Sieg DJ, Hsia DA, Loftus JC, Gaarde WA, Monia BP, Schlaepfer DD: Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res. 2001, 61 (19): 7079-7090.PubMed Hauck CR, Sieg DJ, Hsia DA, Loftus JC, Gaarde WA, Monia BP, Schlaepfer DD: Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res. 2001, 61 (19): 7079-7090.PubMed
15.
go back to reference Chan AY, Coniglio SJ, Chuang YY, Michaelson D, Knaus UG, Philips MR, Symons M: Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene. 2005, 24 (53): 7821-7829. 10.1038/sj.onc.1208909.CrossRefPubMed Chan AY, Coniglio SJ, Chuang YY, Michaelson D, Knaus UG, Philips MR, Symons M: Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene. 2005, 24 (53): 7821-7829. 10.1038/sj.onc.1208909.CrossRefPubMed
16.
go back to reference Conroy H, Mawhinney L, Donnelly SC: Inflammation and cancer: macrophage migration inhibitory factor (MIF)–the potential missing link. QJM. 2010, 103 (11): 831-836. 10.1093/qjmed/hcq148.PubMedCentralCrossRefPubMed Conroy H, Mawhinney L, Donnelly SC: Inflammation and cancer: macrophage migration inhibitory factor (MIF)–the potential missing link. QJM. 2010, 103 (11): 831-836. 10.1093/qjmed/hcq148.PubMedCentralCrossRefPubMed
17.
go back to reference Cooke G, Armstrong ME, Donnelly SC: Macrophage migration inhibitory factor (MIF), enzymatic activity and the inflammatory response. Biofactors. 2009, 35 (2): 165-168. 10.1002/biof.27.CrossRefPubMed Cooke G, Armstrong ME, Donnelly SC: Macrophage migration inhibitory factor (MIF), enzymatic activity and the inflammatory response. Biofactors. 2009, 35 (2): 165-168. 10.1002/biof.27.CrossRefPubMed
18.
go back to reference Bach JP, Rinn B, Meyer B, Dodel R, Bacher M: Role of MIF in inflammation and tumorigenesis. Oncology. 2008, 75 (3–4): 127-133.CrossRefPubMed Bach JP, Rinn B, Meyer B, Dodel R, Bacher M: Role of MIF in inflammation and tumorigenesis. Oncology. 2008, 75 (3–4): 127-133.CrossRefPubMed
19.
go back to reference Bucala R, Donnelly SC: Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity. 2007, 26 (3): 281-285. 10.1016/j.immuni.2007.03.005.CrossRefPubMed Bucala R, Donnelly SC: Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity. 2007, 26 (3): 281-285. 10.1016/j.immuni.2007.03.005.CrossRefPubMed
20.
go back to reference Ralph JA, Ahmed AU, Santos LL, Clark AR, McMorrow J, Murphy EP, Morand EF: Identification of NURR1 as a mediator of MIF signaling during chronic arthritis: effects on glucocorticoid-induced MKP1. Am J Pathol. 2010, 177 (5): 2366-2378. 10.2353/ajpath.2010.091204.PubMedCentralCrossRefPubMed Ralph JA, Ahmed AU, Santos LL, Clark AR, McMorrow J, Murphy EP, Morand EF: Identification of NURR1 as a mediator of MIF signaling during chronic arthritis: effects on glucocorticoid-induced MKP1. Am J Pathol. 2010, 177 (5): 2366-2378. 10.2353/ajpath.2010.091204.PubMedCentralCrossRefPubMed
21.
go back to reference Lehmann LE, Book M, Hartmann W, Weber SU, Schewe JC, Klaschik S, Hoeft A, Stuber F: A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study. J Transl Med. 2009, 7: 100-10.1186/1479-5876-7-100.PubMedCentralCrossRefPubMed Lehmann LE, Book M, Hartmann W, Weber SU, Schewe JC, Klaschik S, Hoeft A, Stuber F: A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study. J Transl Med. 2009, 7: 100-10.1186/1479-5876-7-100.PubMedCentralCrossRefPubMed
22.
go back to reference Shiroeda H, Tahara T, Nakamura M, Shibata T, Nomura T, Yamada H, Hayashi R, Saito T, Yamada M, Fukuyama T: Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokine. 2010, 51 (2): 173-177. 10.1016/j.cyto.2010.05.003.CrossRefPubMed Shiroeda H, Tahara T, Nakamura M, Shibata T, Nomura T, Yamada H, Hayashi R, Saito T, Yamada M, Fukuyama T: Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokine. 2010, 51 (2): 173-177. 10.1016/j.cyto.2010.05.003.CrossRefPubMed
23.
go back to reference Takahashi N, Nishihira J, Sato Y, Kondo M, Ogawa H, Ohshima T, Une Y, Todo S: Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol Med. 1998, 4 (11): 707-714.PubMedCentralPubMed Takahashi N, Nishihira J, Sato Y, Kondo M, Ogawa H, Ohshima T, Une Y, Todo S: Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol Med. 1998, 4 (11): 707-714.PubMedCentralPubMed
24.
go back to reference Hira E, Ono T, Dhar DK, El-Assal ON, Hishikawa Y, Yamanoi A, Nagasue N: Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma. Cancer. 2005, 103 (3): 588-598. 10.1002/cncr.20818.CrossRefPubMed Hira E, Ono T, Dhar DK, El-Assal ON, Hishikawa Y, Yamanoi A, Nagasue N: Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma. Cancer. 2005, 103 (3): 588-598. 10.1002/cncr.20818.CrossRefPubMed
25.
go back to reference Meyer-Siegler KL, Bellino MA, Tannenbaum M: Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma. Cancer. 2002, 94 (5): 1449-1456. 10.1002/cncr.10354.CrossRefPubMed Meyer-Siegler KL, Bellino MA, Tannenbaum M: Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma. Cancer. 2002, 94 (5): 1449-1456. 10.1002/cncr.10354.CrossRefPubMed
26.
go back to reference Binsky I, Haran M, Starlets D, Gore Y, Lantner F, Harpaz N, Leng L, Goldenberg DM, Shvidel L, Berrebi A: IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc Natl Acad Sci USA. 2007, 104 (33): 13408-13413. 10.1073/pnas.0701553104.PubMedCentralCrossRefPubMed Binsky I, Haran M, Starlets D, Gore Y, Lantner F, Harpaz N, Leng L, Goldenberg DM, Shvidel L, Berrebi A: IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc Natl Acad Sci USA. 2007, 104 (33): 13408-13413. 10.1073/pnas.0701553104.PubMedCentralCrossRefPubMed
27.
go back to reference Legendre H, Decaestecker C, Nagy N, Hendlisz A, Schuring MP, Salmon I, Gabius HJ, Pector JC, Kiss R: Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Mod Pathol. 2003, 16 (5): 491-504. 10.1097/01.MP.0000068235.45178.C1.CrossRefPubMed Legendre H, Decaestecker C, Nagy N, Hendlisz A, Schuring MP, Salmon I, Gabius HJ, Pector JC, Kiss R: Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Mod Pathol. 2003, 16 (5): 491-504. 10.1097/01.MP.0000068235.45178.C1.CrossRefPubMed
28.
go back to reference Khan N, Cromer CJ, Campa M, Patz EF: Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. Cancer. 2004, 101 (2): 379-384. 10.1002/cncr.20377.CrossRefPubMed Khan N, Cromer CJ, Campa M, Patz EF: Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. Cancer. 2004, 101 (2): 379-384. 10.1002/cncr.20377.CrossRefPubMed
29.
go back to reference Tomiyasu M, Yoshino I, Suemitsu R, Okamoto T, Sugimachi K: Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance. Clin Cancer Res. 2002, 8 (12): 3755-3760.PubMed Tomiyasu M, Yoshino I, Suemitsu R, Okamoto T, Sugimachi K: Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance. Clin Cancer Res. 2002, 8 (12): 3755-3760.PubMed
30.
go back to reference Lai KN, Leung JC, Metz CN, Lai FM, Bucala R, Lan HY: Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J Pathol. 2003, 199 (4): 496-508. 10.1002/path.1291.CrossRefPubMed Lai KN, Leung JC, Metz CN, Lai FM, Bucala R, Lan HY: Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J Pathol. 2003, 199 (4): 496-508. 10.1002/path.1291.CrossRefPubMed
31.
go back to reference Donnelly SC, Bucala R: Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. Mol Med Today. 1997, 3 (11): 502-507. 10.1016/S1357-4310(97)01133-7.CrossRefPubMed Donnelly SC, Bucala R: Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. Mol Med Today. 1997, 3 (11): 502-507. 10.1016/S1357-4310(97)01133-7.CrossRefPubMed
32.
go back to reference Ren Y, Chan HM, Li Z, Lin C, Nicholls J, Chen CF, Lee PY, Lui V, Bacher M, Tam PK: Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma. Oncogene. 2004, 23 (23): 4146-4154. 10.1038/sj.onc.1207490.CrossRefPubMed Ren Y, Chan HM, Li Z, Lin C, Nicholls J, Chen CF, Lee PY, Lui V, Bacher M, Tam PK: Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma. Oncogene. 2004, 23 (23): 4146-4154. 10.1038/sj.onc.1207490.CrossRefPubMed
33.
go back to reference Jung H, Seong HA, Ha H: Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J Biol Chem. 2008, 283 (29): 20383-20396. 10.1074/jbc.M800050200.CrossRefPubMed Jung H, Seong HA, Ha H: Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J Biol Chem. 2008, 283 (29): 20383-20396. 10.1074/jbc.M800050200.CrossRefPubMed
35.
go back to reference White ES, Strom SR, Wys NL, Arenberg DA: Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity. J Immunol. 2001, 166 (12): 7549-7555.CrossRefPubMed White ES, Strom SR, Wys NL, Arenberg DA: Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity. J Immunol. 2001, 166 (12): 7549-7555.CrossRefPubMed
36.
go back to reference Arenberg DA, Polverini PJ, Kunkel SL, Shanafelt A, Hesselgesser J, Horuk R, Strieter RM: The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. J Leukoc Biol. 1997, 62 (5): 554-562.PubMed Arenberg DA, Polverini PJ, Kunkel SL, Shanafelt A, Hesselgesser J, Horuk R, Strieter RM: The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. J Leukoc Biol. 1997, 62 (5): 554-562.PubMed
37.
go back to reference Arenberg D, Luckhardt TR, Carskadon S, Zhao L, Amin MA, Koch AE: Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair. Am J Respir Crit Care Med. 2010, 182 (8): 1030-1037. 10.1164/rccm.201001-0120OC.PubMedCentralCrossRefPubMed Arenberg D, Luckhardt TR, Carskadon S, Zhao L, Amin MA, Koch AE: Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair. Am J Respir Crit Care Med. 2010, 182 (8): 1030-1037. 10.1164/rccm.201001-0120OC.PubMedCentralCrossRefPubMed
38.
go back to reference Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R: MIF signal transduction initiated by binding to CD74. J Exp Med. 2003, 197 (11): 1467-1476. 10.1084/jem.20030286.PubMedCentralCrossRefPubMed Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R: MIF signal transduction initiated by binding to CD74. J Exp Med. 2003, 197 (11): 1467-1476. 10.1084/jem.20030286.PubMedCentralCrossRefPubMed
39.
go back to reference Shun CT, Lin JT, Huang SP, Lin MT, Wu MS: Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas. World J Gastroenterol. 2005, 11 (24): 3767-3771.PubMedCentralCrossRefPubMed Shun CT, Lin JT, Huang SP, Lin MT, Wu MS: Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas. World J Gastroenterol. 2005, 11 (24): 3767-3771.PubMedCentralCrossRefPubMed
40.
go back to reference Beswick EJ, Pinchuk IV, Minch K, Suarez G, Sierra JC, Yamaoka Y, Reyes VE: The Helicobacter pylori urease B subunit binds to CD74 on gastric epithelial cells and induces NF-kappaB activation and interleukin-8 production. Infect Immun. 2006, 74 (2): 1148-1155. 10.1128/IAI.74.2.1148-1155.2006.PubMedCentralCrossRefPubMed Beswick EJ, Pinchuk IV, Minch K, Suarez G, Sierra JC, Yamaoka Y, Reyes VE: The Helicobacter pylori urease B subunit binds to CD74 on gastric epithelial cells and induces NF-kappaB activation and interleukin-8 production. Infect Immun. 2006, 74 (2): 1148-1155. 10.1128/IAI.74.2.1148-1155.2006.PubMedCentralCrossRefPubMed
41.
go back to reference Gamez-Pozo A, Sanchez-Navarro I, Calvo E, Agullo-Ortuno MT, Lopez-Vacas R, Diaz E, Camafeita E, Nistal M, Madero R, Espinosa E: PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics. PLoS One. 2012, 7 (3): e33752-10.1371/journal.pone.0033752.PubMedCentralCrossRefPubMed Gamez-Pozo A, Sanchez-Navarro I, Calvo E, Agullo-Ortuno MT, Lopez-Vacas R, Diaz E, Camafeita E, Nistal M, Madero R, Espinosa E: PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics. PLoS One. 2012, 7 (3): e33752-10.1371/journal.pone.0033752.PubMedCentralCrossRefPubMed
42.
go back to reference Calandra T, Roger T: Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003, 3 (10): 791-800. 10.1038/nri1200.CrossRefPubMed Calandra T, Roger T: Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003, 3 (10): 791-800. 10.1038/nri1200.CrossRefPubMed
43.
go back to reference Kamimura A, Kamachi M, Nishihira J, Ogura S, Isobe H, Dosaka-Akita H, Ogata A, Shindoh M, Ohbuchi T, Kawakami Y: Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung. Cancer. 2000, 89 (2): 334-341. 10.1002/1097-0142(20000715)89:2<334::AID-CNCR18>3.0.CO;2-N.CrossRefPubMed Kamimura A, Kamachi M, Nishihira J, Ogura S, Isobe H, Dosaka-Akita H, Ogata A, Shindoh M, Ohbuchi T, Kawakami Y: Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung. Cancer. 2000, 89 (2): 334-341. 10.1002/1097-0142(20000715)89:2<334::AID-CNCR18>3.0.CO;2-N.CrossRefPubMed
44.
go back to reference Mitchell RA: Mechanisms and effectors of MIF-dependent promotion of tumorigenesis. Cell Signal. 2004, 16 (1): 13-19. 10.1016/j.cellsig.2003.07.002.CrossRefPubMed Mitchell RA: Mechanisms and effectors of MIF-dependent promotion of tumorigenesis. Cell Signal. 2004, 16 (1): 13-19. 10.1016/j.cellsig.2003.07.002.CrossRefPubMed
45.
go back to reference Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J: Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell Signal. 2006, 18 (5): 688-703. 10.1016/j.cellsig.2005.06.013.CrossRefPubMed Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J: Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell Signal. 2006, 18 (5): 688-703. 10.1016/j.cellsig.2005.06.013.CrossRefPubMed
46.
go back to reference Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH: A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med. 1999, 190 (10): 1375-1382. 10.1084/jem.190.10.1375.PubMedCentralCrossRefPubMed Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH: A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med. 1999, 190 (10): 1375-1382. 10.1084/jem.190.10.1375.PubMedCentralCrossRefPubMed
47.
go back to reference Li GQ, Xie J, Lei XY, Zhang L: Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway. World J Gastroenterol. 2009, 15 (44): 5541-5548. 10.3748/wjg.15.5541.PubMedCentralCrossRefPubMed Li GQ, Xie J, Lei XY, Zhang L: Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway. World J Gastroenterol. 2009, 15 (44): 5541-5548. 10.3748/wjg.15.5541.PubMedCentralCrossRefPubMed
48.
go back to reference Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Luscher B, Bernhagen J: Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene. 2007, 26 (35): 5046-5059. 10.1038/sj.onc.1210318.CrossRefPubMed Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Luscher B, Bernhagen J: Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene. 2007, 26 (35): 5046-5059. 10.1038/sj.onc.1210318.CrossRefPubMed
49.
go back to reference Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE: Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res. 2003, 93 (4): 321-329. 10.1161/01.RES.0000087641.56024.DA.CrossRefPubMed Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE: Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res. 2003, 93 (4): 321-329. 10.1161/01.RES.0000087641.56024.DA.CrossRefPubMed
50.
go back to reference Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R: An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med. 1999, 5 (3): 181-191.PubMedCentralPubMed Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R: An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med. 1999, 5 (3): 181-191.PubMedCentralPubMed
51.
go back to reference Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, Zhang Y, Wang S: Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett. 2008, 261 (2): 147-157. 10.1016/j.canlet.2007.11.028.CrossRefPubMed Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, Zhang Y, Wang S: Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett. 2008, 261 (2): 147-157. 10.1016/j.canlet.2007.11.028.CrossRefPubMed
52.
go back to reference Rao RV, Hermel E, Castro-Obregon S, del Rio G, Ellerby LM, Ellerby HM, Bredesen DE: Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem. 2001, 276 (36): 33869-33874. 10.1074/jbc.M102225200.CrossRefPubMed Rao RV, Hermel E, Castro-Obregon S, del Rio G, Ellerby LM, Ellerby HM, Bredesen DE: Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem. 2001, 276 (36): 33869-33874. 10.1074/jbc.M102225200.CrossRefPubMed
53.
go back to reference Oyadomari S, Araki E, Mori M: Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis. 2002, 7 (4): 335-345. 10.1023/A:1016175429877.CrossRefPubMed Oyadomari S, Araki E, Mori M: Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis. 2002, 7 (4): 335-345. 10.1023/A:1016175429877.CrossRefPubMed
54.
go back to reference Nakagawa T, Yuan J: Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol. 2000, 150 (4): 887-894. 10.1083/jcb.150.4.887.PubMedCentralCrossRefPubMed Nakagawa T, Yuan J: Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol. 2000, 150 (4): 887-894. 10.1083/jcb.150.4.887.PubMedCentralCrossRefPubMed
55.
go back to reference Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y, Manabe T, Yamagishi S, Bando Y, Imaizumi K: Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. J Cell Biol. 2004, 165 (3): 347-356. 10.1083/jcb.200310015.PubMedCentralCrossRefPubMed Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y, Manabe T, Yamagishi S, Bando Y, Imaizumi K: Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. J Cell Biol. 2004, 165 (3): 347-356. 10.1083/jcb.200310015.PubMedCentralCrossRefPubMed
56.
go back to reference Li Z, Zhang T, Dai H, Liu G, Wang H, Sun Y, Zhang Y, Ge Z: Endoplasmic reticulum stress is involved in myocardial apoptosis of streptozocin-induced diabetic rats. J Endocrinol. 2008, 196 (3): 565-572. 10.1677/JOE-07-0230.CrossRefPubMed Li Z, Zhang T, Dai H, Liu G, Wang H, Sun Y, Zhang Y, Ge Z: Endoplasmic reticulum stress is involved in myocardial apoptosis of streptozocin-induced diabetic rats. J Endocrinol. 2008, 196 (3): 565-572. 10.1677/JOE-07-0230.CrossRefPubMed
57.
Metadata
Title
Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis
Authors
Yubiao Guo
Junna Hou
Yifeng Luo
Dujuan Wang
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2013
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-13-28

Other articles of this Issue 1/2013

Cancer Cell International 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine